1MARON DJ, FAZIO S, LINTON MF. Current perspec- tives on statins [J].Circulation, 2000,101 (2) : 207-213.
2SHIMIZU K, AIKAWA M, TAKAYAMA K, et al. Di- rect antiinflammatory mechanisms contribute to attenua- tion of experimental allograft arteriosclerosis by statins [J].Circulation, 2003,108(17) : 2113-2120.
3WILLIAMS JK, SUKHOVA GK, HERRINGTON DM, et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys[J]. J Am Coil Cardiol, 1998,31 (3) :684-691.
4YOSHIDA M,SAWADA T, ISHII H,et al. HMG-CoA inhibitor modulates monocyte-endothelial cell interaction under physiological flow condition in vitro: involvement of Rho GTPase-dependent mechanism [J]. Arterioscler Thromb Vase Biol,2001,21(7) :1165-1171.
5ALBER HF, FRICK M,SUSSENBACHER A, et al. Eff- ect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease[J]. Wien Med Wochenschr, 2007, 157(3-4) :73-78.
6KATZNELSON S, WILKINSON AH, KOBASHIGAWA JA, et al. The effect of pravastatin on acute rejection afterkidney transplantation-a pilot study[J].Transplantation, 1996,61(10) :1469-1474.
7LEUNG BP, SATTAR N,CRILLY A, et al. A novel anti- inflammatory role for simvastatin in inflammatory arthri- tis[J].J Immunol, 2003,170(3) : 1524-1530.
8PALINSKI W. New evidence for beneficial effects of st- atins unrelated to lipid lowering[J]. Arterioscler Thromb Vasc Biol,2001,21(1) :3-5.
9WAGNER AH, SCHWABE O, HECKER M. Atorvasta- tin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ[J]. Br J Pharmacol, 2002,136(1) : 143-149.
10ETO M, KOZAI T, COSENTION F, et al. Statin prevents tissue factor expression in human endothelial cells:role of Rho/Rho2 kinase and Akt pathway [J].Circulation, 2002,105 (15) : 1756-1759.
8The Collaborative Research Group for the Second Multi-center Survey of Clinical Management of Dyslipidemia in China.第二次中国临床血脂控制达标率及影响因素多中心协作研究[J].中华心血管病杂志,2007,35(5):420-427. 被引量：126
10Heart Protec collaborative Group tion Study Ember son J, Bennett D, et al. C-reactive protein concentration and the vascularbenefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study [J]. Lancet, 2011,377 (9764): 469-476.
